Sri Lanka Pharmaceuticals & Healthcare Q4 2019
Despite the recent hike in drug prices, Sri Lanka will remain a challenging market for pharmaceutical suppliers.Healthcare sector investment and development will act as a key driver of market growth over the next few years, ensuring improvedaccess to medical treatment. From a demand-side perspective, the growing burden of chronic diseases will ensure that demand formedical treatment remains high. However, the subdued regulatory and operating environment and the small absolute market sizewill continue to weigh on the market's growth potential.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook